EP1194534A4 - Nouveaux genes codant des proteines pouvant etre utilisees dans des domaines diagnostiques, preventifs, therapeutiques ou autres - Google Patents

Nouveaux genes codant des proteines pouvant etre utilisees dans des domaines diagnostiques, preventifs, therapeutiques ou autres

Info

Publication number
EP1194534A4
EP1194534A4 EP00941494A EP00941494A EP1194534A4 EP 1194534 A4 EP1194534 A4 EP 1194534A4 EP 00941494 A EP00941494 A EP 00941494A EP 00941494 A EP00941494 A EP 00941494A EP 1194534 A4 EP1194534 A4 EP 1194534A4
Authority
EP
European Patent Office
Prior art keywords
preventive
diagnostic
therapeutic
genes encoding
encoding proteins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
EP00941494A
Other languages
German (de)
English (en)
Other versions
EP1194534A2 (fr
Inventor
Susan J Kirst
Douglas A Holtzman
Christopher C Fraser
John D Sharp
Thomas S Barnes
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Millennium Pharmaceuticals Inc
Original Assignee
Millennium Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Millennium Pharmaceuticals Inc filed Critical Millennium Pharmaceuticals Inc
Publication of EP1194534A2 publication Critical patent/EP1194534A2/fr
Publication of EP1194534A4 publication Critical patent/EP1194534A4/fr
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP00941494A 1999-06-29 2000-06-16 Nouveaux genes codant des proteines pouvant etre utilisees dans des domaines diagnostiques, preventifs, therapeutiques ou autres Ceased EP1194534A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US34236499A 1999-06-29 1999-06-29
US342364 1999-06-29
PCT/US2000/016658 WO2001000638A2 (fr) 1999-06-29 2000-06-16 Nouveaux genes codant des proteines pouvant etre utilisees dans des domaines diagnostiques, preventifs, therapeutiques ou autres

Publications (2)

Publication Number Publication Date
EP1194534A2 EP1194534A2 (fr) 2002-04-10
EP1194534A4 true EP1194534A4 (fr) 2004-03-24

Family

ID=23341516

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00941494A Ceased EP1194534A4 (fr) 1999-06-29 2000-06-16 Nouveaux genes codant des proteines pouvant etre utilisees dans des domaines diagnostiques, preventifs, therapeutiques ou autres

Country Status (3)

Country Link
EP (1) EP1194534A4 (fr)
AU (1) AU5619700A (fr)
WO (1) WO2001000638A2 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2332916T3 (es) * 1999-06-09 2010-02-15 Genentech Inc Composiciones y metodo para el tratamiento de tumores.
WO2001057262A1 (fr) * 2000-02-03 2001-08-09 Hyseq, Inc. Procedes et matieres lies aux polypeptides et aux polynucleotides du type molecule de guidage neuronal (du type ngm)
US20060110384A1 (en) * 2002-07-10 2006-05-25 Yuji Matsuzawa Novel proteins and use thereof
EP1447412A1 (fr) * 2003-02-17 2004-08-18 Universiteit Utrecht Holding B.V. Procédé de charactérisation de protéines, protéines isolées et leur utilisation
WO2024138074A1 (fr) * 2022-12-21 2024-06-27 Codexis, Inc. Variants d'inhibiteur de rnase modifiés
CN116223818B (zh) * 2023-05-09 2023-07-21 四川大学华西医院 Dr3蛋白检测试剂在制备筛查aecopd的试剂盒的用途及筛查aecopd的试剂盒

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995026201A1 (fr) * 1994-03-28 1995-10-05 La Jolla Cancer Research Foundation Un proteoglycane de cellule gliale: le brevicane
WO1995027785A1 (fr) * 1994-04-08 1995-10-19 Yale University Behab, une proteine cerebrale de liaison du hyaluronan
WO1998021328A2 (fr) * 1996-11-13 1998-05-22 Sagami Chemical Research Center Proteines humaines possedant des domaines de transmembrane et adn codant ces proteines
WO1998022491A1 (fr) * 1996-11-19 1998-05-28 Millennium Pharmaceuticals, Inc. Procede pour identifier des genes codant de nouvelles proteines secretees ou associees a des membranes
WO1998031799A2 (fr) * 1997-01-21 1998-07-23 Human Genome Sciences, Inc. Polynucleotides et polypeptides codant des recepteurs
WO1998039446A2 (fr) * 1997-03-07 1998-09-11 Human Genome Sciences, Inc. 70 proteines humaines secretees
WO2000075317A2 (fr) * 1999-06-09 2000-12-14 Genentech, Inc. Compositions et methodes de traitement de tumeur
WO2001012662A2 (fr) * 1999-08-17 2001-02-22 Incyte Genomics, Inc. Proteines associees a la membrane

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995026201A1 (fr) * 1994-03-28 1995-10-05 La Jolla Cancer Research Foundation Un proteoglycane de cellule gliale: le brevicane
WO1995027785A1 (fr) * 1994-04-08 1995-10-19 Yale University Behab, une proteine cerebrale de liaison du hyaluronan
WO1998021328A2 (fr) * 1996-11-13 1998-05-22 Sagami Chemical Research Center Proteines humaines possedant des domaines de transmembrane et adn codant ces proteines
WO1998022491A1 (fr) * 1996-11-19 1998-05-28 Millennium Pharmaceuticals, Inc. Procede pour identifier des genes codant de nouvelles proteines secretees ou associees a des membranes
WO1998031799A2 (fr) * 1997-01-21 1998-07-23 Human Genome Sciences, Inc. Polynucleotides et polypeptides codant des recepteurs
WO1998039446A2 (fr) * 1997-03-07 1998-09-11 Human Genome Sciences, Inc. 70 proteines humaines secretees
WO2000075317A2 (fr) * 1999-06-09 2000-12-14 Genentech, Inc. Compositions et methodes de traitement de tumeur
WO2001012662A2 (fr) * 1999-08-17 2001-02-22 Incyte Genomics, Inc. Proteines associees a la membrane

Non-Patent Citations (11)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL [online] 1 November 1997 (1997-11-01), XP002266637, Database accession no. Q28062 *
DATABASE EMBL [online] 1 October 1996 (1996-10-01), XP002266638, Database accession no. P55068 *
DATABASE EMBL [online] 11 December 1998 (1998-12-11), XP002231392, Database accession no. AI304312 *
DATABASE EMBL [online] 12 March 1999 (1999-03-12), XP002231395, Database accession no. AL045370 *
DATABASE EMBL [online] 16 March 1999 (1999-03-16), XP002231394, Database accession no. AI457257 *
DATABASE EMBL [online] 28 January 1999 (1999-01-28), XP002231393, Database accession no. AI380446 *
DATABASE EMBL [online] 28 June 1999 (1999-06-28), XP002231391, Database accession no. AI744799 *
See also references of WO0100638A3 *
SEIDENBECHER CONSTANZE I ET AL: "Brevican, a chondroitin sulfate proteoglycan of rat brain, occurs as secreted and cell surface glycosylphosphatidylinositol-anchored isoforms", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 270, no. 45, 1995, pages 27206 - 27212, XP002266636, ISSN: 0021-9258 *
YAMADA HIDEKAZU ET AL: "Molecular cloning of brevican, a novel brain proteoglycan of the aggrecan/versican family", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 269, no. 13, 1994, pages 10119 - 10126, XP002266635, ISSN: 0021-9258 *
YOKOYAMA-KOBAYASHI M ET AL: "Selection of cDNAs encoding putative type II membrane proteins on the cell surface from a human full-length cDNA bank", GENE, vol. 228, no. 1-2, 4 March 1999 (1999-03-04), pages 161 - 167, XP004159146, ISSN: 0378-1119 *

Also Published As

Publication number Publication date
EP1194534A2 (fr) 2002-04-10
WO2001000638A2 (fr) 2001-01-04
AU5619700A (en) 2001-01-31
WO2001000638A3 (fr) 2001-07-05

Similar Documents

Publication Publication Date Title
HUP0203506A3 (en) Modified peptides as therapeutic agents
MXPA02010787A (es) Peptidos modificados como agentes terapeuticos.
EP1210416A4 (fr) Nouveaux genes codant pour des proteines a des fins de diagnostic, de prevention, de therapie et autres
AU6246199A (en) Human interleukin-b50, therapeutic uses
AU2002303261A8 (en) Gene brcc2 and diagnostic and therapeutic uses thereof
HUP0104825A3 (en) Genes and proteins, and their use
EP1218392A4 (fr) Nouveaux genes codant pour des proteines a usages previsionnel, diagnostique therapeutique et autres
EP1194534A4 (fr) Nouveaux genes codant des proteines pouvant etre utilisees dans des domaines diagnostiques, preventifs, therapeutiques ou autres
AU1138699A (en) Dna demethylase, therapeutic and diagnostic uses thereof
AU1509501A (en) A novel polypeptide, a human deafness-related gene 14 and the polynucleotide encoding the polypeptide
EP1240198A4 (fr) Nouveaux genes codant des proteines utilisees dans des applications pronostiques, diagnostiques, preventives et therapeutiques
AU2769101A (en) Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses
MXPA02002767A (es) Usos terapeuticos del polipeptido m3.
WO2001011039A3 (fr) Nouveaux variants de sequences du gene humain de l'adrenorecepteur $g(b)1
GB0217548D0 (en) Four human zinc-finger-containing proteins:MDZ3.MDZ4,MDZ7 and MDZ12
AU5904400A (en) Novel genes encoding proteins having diagnostic, preventive, therapeutic, and other uses
WO2002072611A8 (fr) Nouvelles proteines humaines de la famille egf et polynucleotides codant pour ces proteines
AU2001266844A1 (en) Novel human seven transmembrane proteins and polynucleotides encoding the same
AU2001274923A1 (en) Novel human thrombospondin-like proteins and polynucleotides encoding the same
ZA200005703B (en) IL-17 homologous polypeptides and therapeutic uses thereof.
AU5309500A (en) Novel human genes and proteins encoded thereby
AU5760200A (en) Human genes and proteins encoded thereby
AU4726901A (en) Novel human proteins and polynucleotides encoding the same
AU3010199A (en) Human leupaxin polypeptide and dna encoding it, their uses
GB9926811D0 (en) Combined rapid diagnosis and therapy

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20020122

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

RIN1 Information on inventor provided before grant (corrected)

Inventor name: KIRST, SUSAN, J.

Inventor name: FRASER, CHRISTOPHER, C.

Inventor name: BARNES, THOMAS, S.

Inventor name: HOLTZMAN, DOUGLAS, A.

Inventor name: SHARP, JOHN, D.

RIC1 Information provided on ipc code assigned before grant

Ipc: 7G 01N 33/50 B

Ipc: 7C 12N 15/00 A

Ipc: 7C 12Q 1/68 B

Ipc: 7C 07K 14/47 B

A4 Supplementary search report drawn up and despatched

Effective date: 20040209

APBK Appeal reference recorded

Free format text: ORIGINAL CODE: EPIDOSNREFNE

APBN Date of receipt of notice of appeal recorded

Free format text: ORIGINAL CODE: EPIDOSNNOA2E

APBR Date of receipt of statement of grounds of appeal recorded

Free format text: ORIGINAL CODE: EPIDOSNNOA3E

APAF Appeal reference modified

Free format text: ORIGINAL CODE: EPIDOSCREFNE

REG Reference to a national code

Ref country code: DE

Ref legal event code: R003

APBT Appeal procedure closed

Free format text: ORIGINAL CODE: EPIDOSNNOA9E

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED

18R Application refused

Effective date: 20111213